Form 8-K - Current report:
SEC Accession No. 0001493152-19-018313
Filing Date
2019-11-25
Accepted
2019-11-25 09:00:25
Documents
3
Period of Report
2019-11-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 46230
2 ex4-1.htm EX-4.1 25177
3 ex10-1.htm EX-10.1 111425
  Complete submission text file 0001493152-19-018313.txt   184262
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 191243864
SIC: 2834 Pharmaceutical Preparations